BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 24581976)

  • 1. Variability of hemoglobin F expression in hemoglobin EE disease: hematological and molecular analysis.
    Pakdee N; Yamsri S; Fucharoen G; Sanchaisuriya K; Pissard S; Fucharoen S
    Blood Cells Mol Dis; 2014; 53(1-2):11-5. PubMed ID: 24581976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients.
    Nguyen TK; Joly P; Bardel C; Moulsma M; Bonello-Palot N; Francina A
    Blood Cells Mol Dis; 2010 Aug; 45(2):124-7. PubMed ID: 20472475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Understanding of Non-Transfusion-Dependent Thalassemia Associated with Hemoglobin E-β-Thalassemia in Northeast Thailand.
    Yamsri S; Pakdee N; Fucharoen G; Sanchaisuriya K; Fucharoen S
    Acta Haematol; 2016; 136(4):233-239. PubMed ID: 27710960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Modifiers of Sickle Cell Disease: A Genotype-Phenotype Relationship Study in a Cohort of 82 Children on Mayotte Island.
    Muszlak M; Pissard S; Badens C; Chamouine A; Maillard O; Thuret I
    Hemoglobin; 2015; 39(3):156-61. PubMed ID: 25806420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic expression of Hb F in common high Hb F determinants in Thailand: roles of α-thalassemia, 5' δ-globin BCL11A binding region and 3' β-globin enhancer.
    Prakobkaew N; Fucharoen S; Fuchareon G; Siriratmanawong N
    Eur J Haematol; 2014 Jan; 92(1):73-9. PubMed ID: 24112054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Genetic Polymorphisms and Hb F Levels in Heterozygous β-Thalassemia 3.5 kb Deletions.
    Tepakhan W; Kanjanaopas S; Srewaradachpisal K
    Hemoglobin; 2020 Sep; 44(5):338-343. PubMed ID: 32878504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of BCL11A, HBS1L-MYB, HBBP1 single nucleotide polymorphisms and the HBG2 XmnI polymorphism On Hb F levels.
    Roy P; Bhattacharya G; Mandal A; Dasgupta UB; Banerjee D; Chandra S; Das M
    Hemoglobin; 2012; 36(6):592-9. PubMed ID: 23094636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances: A study on β-thalassemia and hemoglobin E/β-thalassemia patients in Indonesia.
    Rujito L; Basalamah M; Siswandari W; Setyono J; Wulandari G; Mulatsih S; Sofro AS; Sadewa AH; Sutaryo S
    Hematol Oncol Stem Cell Ther; 2016 Jun; 9(2):55-63. PubMed ID: 27009595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel SNP rs11759328 on Rho GTPase-activating protein 18 gene is associated with the expression of Hb F in hemoglobin E-related disorders.
    Jomoui W; Tepakhan W; Yamsri S; Srivorakun H; Fucharoen G; Fucharoen S
    Ann Hematol; 2020 Jan; 99(1):23-29. PubMed ID: 31776727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Analysis of Non-Transfusion Dependent Thalassemia Associated with Hemoglobin E-β-Thalassemia Disease without α-Thalassemia.
    Phanrahan P; Yamsri S; Teawtrakul N; Fucharoen G; Sanchaisuriya K; Fucharoen S
    Mediterr J Hematol Infect Dis; 2019; 11(1):e2019038. PubMed ID: 31308914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of XmnI-HBG2, BCL11A and HBS1L-MYB Single Nucleotide Polymorphisms on Hb F Variation of Hematologically Normal Iranian Individuals.
    Keyhani E; Jafari Vesiehsari M; Talebi Kakroodi S; Darabi E; Zamani F; Karimlou M; Kamali K; Neishabury M
    Hemoglobin; 2016 Jun; 40(3):198-201. PubMed ID: 27117569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Trait Loci Influencing Hb F Levels in Southern Thai Hb E (HBB: c.79G>A) Heterozygotes.
    Kesornsit A; Jeenduang N; Horpet D; Plyduang T; Nuinoon M
    Hemoglobin; 2018 Jan; 42(1):23-29. PubMed ID: 29457528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemoglobin EE disease in young Laotian children: Hematologic features and the contributions of genetic variations to Hb F expression.
    Arong A; Srivorakun H; Chaibunruang A; Fucharoen S; Fucharoen G; Kounnavong S; Sanchaisuriya K
    Int J Lab Hematol; 2023 Jun; 45(3):387-393. PubMed ID: 36597281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal hemoglobin regulating genetic variants identified in homozygous (HbSS) and heterozygous (HbSA) subjects from South Mexico.
    Rizo-de la Torre LC; Borrayo-López FJ; Perea-Díaz FJ; Aquino E; Venegas M; Hernández-Carbajal C; Espinoza-Mata LL; Ibarra-Cortés B
    J Trop Pediatr; 2022 Aug; 68(5):. PubMed ID: 36130307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of HBG2, BCL11A, and HBS1L-MYB polymorphisms to thalidomide response in Chinese β-thalassemia patients.
    Yang K; Wu Y; Ma Y; Xiao J; Zhou Y; Yin X
    Blood Cells Mol Dis; 2020 Sep; 84():102442. PubMed ID: 32387854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nine known and five novel mutations in the erythroid transcription factor KLF1 gene and phenotypic expression of fetal hemoglobin in hemoglobin E disorder.
    Tepakhan W; Yamsri S; Sanchaisuriya K; Fucharoen G; Xu X; Fucharoen S
    Blood Cells Mol Dis; 2016 Jul; 59():85-91. PubMed ID: 27282573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential genetic modifiers and their measurable impact in a community-recruited population analysis for non-severe hemoglobin E/β-thalassemia prenatal genetic counseling.
    Wong P; Chitsobhak T; Jittasathian S; Sirichantharawat C; Cherdchoo N; Prangcharoen W; Jongautchariyakul P; Jampachaisri K; Tapprom A; Deoisares R; Chumnumsiriwath P
    Blood Cells Mol Dis; 2023 Nov; 103():102765. PubMed ID: 37353362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia.
    Sales RR; Belisário AR; Faria G; Mendes F; Luizon MR; Viana MB
    Ann Hematol; 2020 Jul; 99(7):1453-1463. PubMed ID: 32447424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Modifiers in β-Thalassemia Intermedia: A Study on 102 Iraqi Arab Patients.
    Al-Allawi NA; Puehringer H; Raheem RA; Oberkanins C
    Genet Test Mol Biomarkers; 2015 May; 19(5):242-7. PubMed ID: 25751242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The correlation of α-globin gene mutations and the XmnI polymorphism with clinical severity of Hb E/β-thalassemia.
    Charoenkwan P; Teerachaimahit P; Sanguansermsri T
    Hemoglobin; 2014; 38(5):335-8. PubMed ID: 25238043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.